VIBEKE STRAND, M.D.
Osteopathic Medicine at Ramona Rd, Menlo Park, CA
License number
California G39513
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
306 Ramona Rd, Menlo Park, CA 94028
Phone
(650) 529-0150
(650) 529-0225 (Fax)
(650) 529-0225 (Fax)
Personal information
See more information about VIBEKE STRAND at radaris.comName
Address
Phone
Woodside, CA
306 Ramona Rd, Portola Valley, CA 94028
546 29Th St, San Francisco, CA 94131
Organization information
See more information about VIBEKE STRAND at bizstanding.comVibeke Strand MD
306 Ramona Rd, Portola Valley, CA 94028
Industry:
Internist
Phone:
(650) 529-0150 (Phone)
Description:
There is 1 doctor at this site. Surgery is not performed at this site.
Vibeke Vibeke Strand
Categories:
Rheumatology Physicians & Surgeons
Professional information
Dr. Vibeke Strand, Portola Valley CA - MD (Doctor of Medicine)
Specialties:
Allergy & Immunology, Immunology, Pediatric Allergy & Immunology, Pediatric Clinical & Laboratory Immunology
Address:
Vibeke Strand MD
306 Ramona Rd, Portola Valley 94028
(650) 529-0150 (Phone)
306 Ramona Rd, Portola Valley 94028
(650) 529-0150 (Phone)
Languages:
English
Hospitals:
Vibeke Strand MD
306 Ramona Rd, Portola Valley 94028
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
306 Ramona Rd, Portola Valley 94028
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University of California At San Francisco
Graduated: 1976
Mich State University Assoc Hospital
University Of California San Francisco
University of California At San Francisco
Graduated: 1976
Mich State University Assoc Hospital
University Of California San Francisco
Methods Of Improving Health-Related Quality Of Life In Individuals With Systemic Lupus Erythematosus
US Patent:
2007021, Sep 20, 2007
Filed:
Nov 21, 2006
Appl. No.:
11/562174
Inventors:
Vibeke Strand - Portola Valley CA, US
Matthew Linnik - Solana Beach CA, US
Tenshang Joh - Encinitas CA, US
Matthew Linnik - Solana Beach CA, US
Tenshang Joh - Encinitas CA, US
International Classification:
A61K 39/385, A61K 39/00
US Classification:
424185100, 424184100, 424193100
Abstract:
The invention provides methods for stabilizing or improving the health-related quality of life in individuals with SLE, and methods of selecting individuals suitable for such treatment. One method of stabilizing or improving the health-related quality of life of an individual with SLE involves the administration of an effective amount of dsDNA epitope, such as in the form of an epitope-presenting carrier or an epitope-presenting valency platform molecule like LJP 394, to the individual. The invention further provides a method of stabilizing or improving the health-related quality of life of an individual with SLE involving the reduction of the level of SLE-associated antibodies in the individual, optionally through administration of a dsDNA epitope to the individual. In addition, methods of screening patients are provided. Kits useful in the methods of the invention are also provided.
Methods Of Improving Health-Related Quality Of Life In Individuals With Systemic Lupus Erythematosus
US Patent:
2004020, Oct 21, 2004
Filed:
Dec 29, 2003
Appl. No.:
10/748541
Inventors:
Vibeke Strand - Portola Valley CA, US
Matthew Linnik - Solana Beach CA, US
Tenshang Joh - Encinitas CA, US
Matthew Linnik - Solana Beach CA, US
Tenshang Joh - Encinitas CA, US
International Classification:
C12Q001/68, A61K039/395
US Classification:
424/130100, 435/006000
Abstract:
The invention provides methods for stabilizing or improving the health-related quality of life in individuals with SLE, and methods of selecting individuals suitable for such treatment. One method of stabilizing or improving the health-related quality of life of an individual with SLE involves the administration of an effective amount of dsDNA epitope, such as in the form of an epitope-presenting carrier or an epitope-presenting valency platform molecule like LJP 394, to the individual. The invention further provides a method of stabilizing or improving the health-related quality of life of an individual with SLE involving the reduction of the level of SLE-associated antibodies in the individual, optionally through administration of a dsDNA epitope to the individual. In addition, methods of screening patients are provided. Kits useful in the methods of the invention are also provided.